Brussels, 29 January 2026 – EuropaBio submitted a cross-sectoral response to the European Commission public consultation on the revision of the Public Procurement Directives. EuropaBio’s response highlighted the need for a holistic assessment of biotech products, including for biomanufacturing and particularly for health, that consider criteria beyond price such as sustainability, environmental and social impact and innovation brought by the product.. EuropaBio also highlighted that the EU must recognise the global nature of health biotechnologies supply chains and therefore prioritise strategic partnerships, avoid uncoordinated national initiatives and pursue regulatory cooperation. EuropaBio also called for an improved access to SMEs to public procurement as they are the vital engine of the EU’s economy and should be facilitated access to these critical economic opportunities. For bio-based products and biotech applications outside of healthcare, EuropaBio support expanding the scope of public procurement to cover both sustainable public procurement and green public procurement.

For the full consultation download the document below.